Baylor Genetics experts Dr. Christine Eng, CMO, CQO, and Dr. Xiaonan Zhao, Associate Clinical Director, discuss the transformative role of RNAseq with WES/WGS in complex and rare disease diagnostics.  

Key Highlights  

• The evolution and significance of RNAseq in clinical settings  
• Comprehensive testing processes and criteria for variant eligibility at Baylor Genetics  
• How RNAseq has been utilized to clarify variants identified through WES/WGS 

To watch the video, please
enter your information.